Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
The 6 a.m. CFO: How Everphone’s Veronika von Heise-Rotenburg Starts Her Day
Heise-Rotenburg shares her morning pet routine, foraging for herbs for daily homemade tea, and how narrow focus relieves her work-related stress.
By
CFO Editorial Staff
| June 1, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
The 6 a.m. CFO: How Everphone’s Veronika von Heise-Rotenburg Starts Her Day
Heise-Rotenburg shares her morning pet routine, foraging for herbs for daily homemade tea, and how narrow focus relieves her work-related stress.
By
CFO Editorial Staff
| June 1, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
Momenta Pharmaceuticals
Mergers & Acquisitions
Johnson & Johnson Borrows $7.5B to Fund Its Purchase Of Momenta
S&P Global Ratings said that the company’s adjusted debt to a measure of earnings is at a 15-year high.
By
Vincent Ryan
| August 21, 2020
Read More
M&A
Johnson & Johnson to Buy Momenta for $6.5B
The deal will give J&J control of nipocalimab, an experimental therapy Momenta is developing to treat autoimmune diseases.
By
Lauren Muskett
| August 19, 2020
Read More
Regulation
Hedge Fund Manager Accused of Insider Trading
The manager traded in advance of FDA announcements approving the sale of generic drugs.
By
Matthew Heller
| June 16, 2016
Read More
